Vera Therapeutics (VERA) Earnings Date, Estimates & Call Transcripts $24.24 +0.47 (+1.98%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$24.16 -0.08 (-0.33%) As of 09/15/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vera Therapeutics Earnings Summary Vera Therapeutics posted Q2 2025 earnings on August 5, 2025, reporting an EPS of -$1.20, which missed the consensus estimate of -$0.82 by $0.38. With a trailing EPS of -$3.58, Vera Therapeutics' earnings are expected to decrease next year, from ($2.89) to ($3.13) per share. Upcoming Q3 Earnings DateNov. 6Before Market OpensEstimatedConsensus EPS (Aug. 5) -$0.82 Actual EPS (Aug. 5) -$1.20 Missed By -$0.38 Q2 2025 Earnings ResourcesQ2 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)VERA Upcoming EarningsVera Therapeutics' next earnings date is estimated for Thursday, November 6, 2025, based on past reporting schedules. Powered by Get Vera Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vera Therapeutics and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataVERA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Vera Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.81-$0.72-$0.77Q2 20253-$0.90-$0.70-$0.81Q3 20253-$1.20-$1.02-$1.13Q4 20253-$1.22-$1.00-$1.14 FY 2025 11 -$4.13 -$3.44 -$3.84 Q1 20262-$1.23-$0.94-$1.09Q2 20262-$1.32-$0.90-$1.11Q3 20262-$1.38-$0.95-$1.17Q4 20262-$1.13-$0.31-$0.72 Vera Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/6/2025(Estimated)--------8/5/2025Q2 2025-$0.82-$1.20 -$0.38-$1.20--5/8/2025Q1 2025-$0.75-$0.81 -$0.06-$0.81--2/26/2025Q4 2024-$0.83-$0.72+$0.11-$0.72--11/7/2024Q3 2024-$0.64-$0.85 -$0.21-$0.85--8/8/2024Q2 2024-$0.56-$0.62 -$0.06-$0.62--5/9/2024Q1 2024-$0.53-$0.56 -$0.03-$0.56--3/20/2024Q4 2023-$0.53-$0.58 -$0.05-$0.58--11/9/2023Q3 2023-$0.50-$0.45+$0.05-$0.45-- Vera Therapeutics Earnings - Frequently Asked Questions When is Vera Therapeutics' earnings date? Vera Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 6th, 2025 based off last year's report dates. Learn more on VERA's earnings history. Did Vera Therapeutics beat their earnings estimates last quarter? In the previous quarter, Vera Therapeutics (NASDAQ:VERA) missed the analysts' consensus estimate of ($0.82) by $0.38 with a reported earnings per share (EPS) of ($1.20). Learn more on analysts' earnings estimate vs. VERA's actual earnings. How much profit does Vera Therapeutics generate each year? Vera Therapeutics (NASDAQ:VERA) has a recorded net income of -$152.15 million. VERA has generated -$3.58 earnings per share over the last four quarters. What is Vera Therapeutics' EPS forecast for next year? Vera Therapeutics' earnings are expected to decrease from ($2.89) per share to ($3.13) per share in the next year. More Earnings Resources from MarketBeat Related Companies NUVL Earnings Date TGTX Earnings Date MRUS Earnings Date CRSP Earnings Date PTCT Earnings Date KRYS Earnings Date PCVX Earnings Date ACAD Earnings Date ACLX Earnings Date ADMA Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Wall Street Eyes +30% Upside in Synopsys After Huge Earnings FallRH Stock Slides After Mixed Earnings and Tariff ConcernsCelsius Stock Surges After Blowout Earnings and Pepsi DealWhy DocuSign Could Be a SaaS Value Play After Q2 EarningsWhy Broadcom's Q3 Earnings Were a Huge Win for AVGO BullsAffirm Crushes Earnings Expectations, Turns Bears into BelieversAmbarella's Earnings Prove Its Edge AI Strategy Is a Winner This page (NASDAQ:VERA) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.